Pathogenesis of nonsteroidal anti-inflammatory drug gastropathy: Clues to preventative therapy

Canadian Journal of Gastroenterology

Volumn 13, Issue 2, 1999, Pages 123-127

  Bastaki, Salim M A ^a   Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acid secretion; H2 receptor antagonists; Nonsteroidal anti inflammatory drugs; Proton pump inhibitors; Ulcer

Indexed keywords

GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

CONFERENCE PAPER; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; LONG TERM CARE; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; STOMACH ACID SECRETION; STOMACH MUCOSA; STOMACH MUCOSA BLOOD FLOW; STOMACH ULCER;

EID: 0032920071     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/738968     Document Type: Conference Paper

References (54)

1. Fromm D. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses? Clin Invest Med 1987;10:251-8.
2. Somasundaram S, Hayllar H, Rafi S, Wrigglesworth JM, Macpherson AJS, Bjarnason I. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol 1995;30:289-99.
3. Lichtenberger LM. The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 1995;57:565-83.
4. Goddard PJ, Hills BA, Lichtenberger LM. Does aspirin damage canine gastric mucosa by reducing its hydrophobicity? Am J Physiol 1987;252:G421-30.
5. Lichtenberger LM, Wang ZM, Romero JJ, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med 1995;I:154-8.
6. Lichtenberger LM, Wang ZM, Giraud MN, Romero JJ, Barretto JC. Effect of naproxen on gastric mucosal hydrophobicity. Gastroenterology 1995;108:A149. (Abst)
7. Mahmud T, Wrigglesworth JM, Scott DL, Bjarnason I. Mitochondrial function and modification of NSAID carboxyl moiety. Inflammopharmacology 1996;42:189-94.
8. Estes LL, Fuhs DW, Heaton AH, Butwinick CS. Gastric ulcer perforation, associated with the use of injectable ketorolac. Ann Pharmacother 1993;27:42-3.
9. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993;10:1078-88.
10. Wallace JL, McKnight GW. Characterization of a simple animal model for nonsteroidal anti-inflammatory drug induced antral ulcer. Can J Physiol Pharmacol 1993;71:447-52.
11. Graham DY, Smith JL, Holmes GI, Davies RO. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa. Clin Pharmacol Ther 1985;38:65-70.
12. Carson JL, Strom BL, Soper KA, West SL, Morse L. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 1987;147:1054-9.
13. Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol 1991;32:77-83.
14. Lanza FL. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1989;163:24-31.
15. Rainsford KD, Willis C. Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production. Dig Dis Sci 1982;27:624-35.
16. Wallace JL, McCafferty D-M, Carter L, McKnight, W, Argentieri D. Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy. Gastroenterology 1993;105:1630-6.
17. Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981;80:94-8.
18. Wallace JL, Tigley AW. New insights into prostaglandins and mucosal defence. Aliment Pharmacol Ther 1995;9:227-35.
19. Whittle BJR. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile salts, and the actions of prostaglandins. Br J Pharmacol 1977;60:455-60.
20. Ashley SW, Sonnenschein LA, Cheung LY. Focal gastric mucosal blood flow at the site of aspirin-induced ulceration. Am J Surg 1985;149:53-9.
21. Kitahora T, Guth PH. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 1987;93:810-7.
22. Gana TJ, Huhlewych R, Koo J. Focal gastric mucosal blood flow in aspirin-induced ulceration. Ann Surg 1987;205:399-403.
23. Rainsford KD. Microvascular injury during gastric damage by anti-inflammatory drugs in pigs and rats. Agents Actions 1983;13:457-60.
24. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990;259:G462-7.
25. Asako H, Kubes P, Wallace JL, Gaginella T, Wolf RE, Granger DN. Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am J Physiol 1992;262:G903-8.
26. Asako H, Kubes P, Wallace JL, Wolf RE, Granger DN. Modulation of leukocyte adhesion to rat mesenteric venules by aspirin and salicylate. Gastroenterology 1992;103:146-52.
27. Wallace JL, McKnight W, Miyasaka M, et al. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol 1993;265:G993-8.
28. Wallace JL, McKnight GW. The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin. Gastroenterology 1990;99:295-304.
29. Lee M, Lee AK, Feldman M. Aspirin-induced acute gastric mucosal injury is a neutrophil-dependent process in rats. Am J Physiol 1992;263:G920-6.
30. Wallace JL, Arfors K-E, McKnight GW. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 1991;100:878-83.
31. Wallace JL, Granger DN. Pathogenesis of NSAID-gastropathy: are neutrophils the culprits? Trends Pharmacol Sci 1992;13:129-31.
32. Del Soldato P, Foschi D, Benoni G, Scarpignato C. Oxygen free radicals interact with indomethacin to cause gastrointestinal injury. Agents Actions 1985;17:484-8.
33. Vaananen PM, Meddings JB, Wallace JL. Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol 1991;261:G470-5.
34. Morris GP, Wallace JL. The roles of ethanol and of acid in the production of gastric mucosal erosions in rats. Virchows Arch B Cell Pathol Incl Mol Pathol 1981;38:23-38.
35. Svanes K, Ito S, Takeuchi K, Silen W. Restitution of the surface epithelium of the in vitro frog gastric mucosa after damage with hyperosmolar sodium chloride. Gastroenterology 1982;82:1409-26.
36. Lacy ER, Ito S. Rapid epithelial restitution of the rat gastric mucosa after ethanol injury. Lab Invest 1984;51:573-83.
37. Moore R, Carlson S, Madara JL. Rapid barrier restitution in an in vitro model of intestinal epithelial injury. Lab Invest 1989;60:237-44.
38. Wallace JL, Whittle BJR. Role of mucus in repair of gastric epithelial damage in the rat. Inhibition of epithelial recovery by mucolytic agents. Gastroenterology 1986;91:603-11.
39. Black BA, Morris GP, Wallace JL. Effects of acid on the basal lamina of the rat stomach and duodenum. Virchows Arch B Cell Pathol Incl Mol Pathol 1985;50:109-18.
40. Rashid F, Toffolon EP. Misoprostol healed a benign nonsteroidal antiinflammatory drug-induced gastric ulcer in a patient with pentagastrin-fast achlorhydria. J Clin Gastroenterol 1993;16:219-21.
41. Janssen M, Dijkmans BA, Vanderbroucke JP, Biemond I, Lamers CB. Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use. Dig Dis Sci 1994;39:362-5.
42. Agrawal NM. Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract. Br J Rheumatol 1995;34(Suppl 1):5-10.
43. Koch M, Capurso L, Dezi A, Ferrario F, Scarpignato C. Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists. Dig Dis 1995;13(Suppl 1):62-74.
44. Simon TJ, Berger ML, Hoover ME, Stauffer LA, Berline RG. A dose-ranging study of famotidine in prevention of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugs (NSAIDs): results of a US multicenter trial. Am J Gastroenterol 1994;89:1644. (Abst)
45. Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996;334:1435-9.
46. Graham DY. Famotidine to prevent peptic ulcer caused by NSAIDs. N Engl J Med 1996;335:1322.
47. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998;338:727-34.
48. Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74:38-43.
49. Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, Kato K. Accelerated healing of duodenal ulcers by oral administration of a basic fibroblast growth factor in rats. Gastroenterology 1994;106:1106-11.
50. Soll AH. Mechanisms of action of antisecretory drugs: studies on isolated canine fundic mucosal cells. Scand J Gastroenterol 1986;21:1-6.
51. Ligumsky M, Goto Y, Yamada T. Prostaglandins mediate inhibition of gastric acid secretion by somatostatin in the rat. Science 1983;219:301-3.
52. Xie W, Robertson DL, Simmons DL. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs. Drug Dev Res 1992;25:249-65.
53. Wallace JL, Bak A, McKnight W, Asfaha S, Sharkey KA, MacNaughton WK. Cyclooxygenase-1 contributes to inflammatory responses in rats and mice: implications for GI toxicity. Gastroenterology 1998;115:101-9.
54. Wallace JL, Elliott SN, Del Soldato P, McKnight W, Sannicolo F, Cirino G. Gastrointestinal sparing anti-inflammatory drugs: The development of nitric oxide-releasing NSAIDs. Drug Dev Res 1997;42:144-9.